Carrera Capital Advisors Has $3.75 Million Stock Position in Colgate-Palmolive Company (NYSE:CL)

Key Points

• Carrera Capital Advisors increased its stake in Colgate-Palmolive by 11.8%, holding 40,014 shares valued at approximately $3.75 million, making it the fund's 22nd largest position.
• Colgate-Palmolive recently reported $0.91 EPS for the quarter, exceeding estimates, although revenue decreased by 3% year-over-year, totaling $4.91 billion.
• The company announced a quarterly dividend of $0.52 per share, reflecting a dividend yield of 2.37% and a payout ratio of 58.76%.

Carrera Capital Advisors raised its holdings in Colgate-Palmolive Company (NYSE:CL - Free Report) by 11.8% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 40,014 shares of the company's stock after buying an additional 4,227 shares during the quarter. Colgate-Palmolive accounts for about 0.8% of Carrera Capital Advisors' investment portfolio, making the stock its 22nd largest position. Carrera Capital Advisors' holdings in Colgate-Palmolive were worth $3,749,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Personal CFO Solutions LLC acquired a new stake in shares of Colgate-Palmolive during the 1st quarter worth approximately $285,000. Aviva PLC lifted its position in shares of Colgate-Palmolive by 13.4% during the 4th quarter. Aviva PLC now owns 973,421 shares of the company's stock worth $88,494,000 after buying an additional 114,855 shares during the period. Vision Capital Management Inc. bought a new position in shares of Colgate-Palmolive during the 1st quarter worth approximately $322,000. Autumn Glory Partners LLC lifted its position in shares of Colgate-Palmolive by 67.4% during the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock worth $851,000 after buying an additional 3,586 shares during the period. Finally, Financial Gravity Asset Management Inc. bought a new position in shares of Colgate-Palmolive during the 1st quarter worth approximately $2,166,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Down 0.6%

NYSE CL opened at $87.93 on Friday. The stock has a fifty day moving average of $90.24 and a 200-day moving average of $90.37. The stock has a market capitalization of $71.26 billion, a P/E ratio of 24.84, a price-to-earnings-growth ratio of 4.53 and a beta of 0.37. Colgate-Palmolive Company has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.54 and a current ratio of 0.85.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The company had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. During the same period last year, the firm earned $0.86 EPS. The business's revenue for the quarter was down 3.0% on a year-over-year basis. On average, equities research analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.37%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.76%.

Analysts Set New Price Targets

Several research firms recently commented on CL. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Wells Fargo & Company raised their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research report on Wednesday, April 2nd. Citigroup raised their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $103.00 to $99.00 and set an "overweight" rating for the company in a research report on Friday. Finally, UBS Group cut their target price on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a research report on Thursday, July 17th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $100.77.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.